Reference to the complete price list for a bottle of aprocitentan

Aprocitentan (Aprocitentan) is a new type of endothelin receptor antagonist, mainly used to treat patients with refractory hypertension who cannot effectively control their blood pressure even with three or more antihypertensive drugs. This drug reduces vasoconstriction by dually blocking ET-A and ET-B receptors, thus achieving a blood pressure lowering effect. It was approved for marketing by European and American countries in 2023 and has gradually become an emerging treatment option in the field of hypertension.

As of2025, aprecitentan has not yet been officially launched in mainland China, which means that domestic patients cannot purchase this drug through hospitals or pharmacies for the time being. If you need to use this drug for treatment, you can currently only obtain it through formal overseas channels, such as overseas medical service institutions, cross-border medical platforms or qualified drug purchasing agents. You need to pay attention to ensure that the channels are legal and the drugs are genuine to ensure drug safety.

At present, the price of aprexitentan in overseas markets is relatively high, especially the price of the original drug in countries such as Europe and the United States, which may reach several thousand to tens of thousands of yuan per bottle, which is a considerable expense for patients with hypertension who need to take medicine for a long time. However, with the emergence of generic drugs, price pressure has eased. In particular, the generic version of Aprecitentan, which has been legally marketed in Laos, has the latest price of about a few hundred yuan per bottle, which is more affordable and more suitable for patients with limited financial ability.

Although generic drugs have obvious advantages in price, patients should still conduct an evaluation under the guidance of a doctor to confirm the indications and drug safety before use. In general, as an innovative antihypertensive drug, aprecitentan's efficacy has been clinically recognized. If it can be launched in China and included in medical insurance in the future, its accessibility and popularity will be greatly improved. Prior to this, choosing overseas channels to obtain Laos generic drugs may be one of the more feasible options at present.

Reference materials:https://go.drugbank.com/drugs/DB15059

xa0